News
Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the U.S. to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer. The guidelines were published on July 9 by a panel of experts in HIV
Training Program for Physician Scientists Fosters Collaboration, Innovation
The Helen Diller Family Comprehensive Cancer Center (HDFCCC) congratulates the first two graduates of the HDFCCC K12 Physician Scientist Program in Clinical Oncology (PSPCO). Launched in 2022 by the Office of Education and Training, the program was designed to train clinical scientists to
UCSF Medical Center Ranks Among Nation’s Exceptional Hospitals
UCSF Medical Center has again been named as one of the country’s top hospitals for patient care and safety, appearing on the national Honor Roll in U.S. News & World Report’s Best Hospitals rankings for 2024-2025. Top 10 Nationwide (national rank shown) #3 Neurology and Neurosurgery – Best in the
Prostate Cancer Test Is Missing Early Disease in Transgender Women
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC San Francisco. The researchers found that transwomen scored 50 times lower than typical PSA tests
UCSF Scientists Win Pew Awards for Cancer and Neuroscience Research
Three UC San Francisco scientists have received 2024 Pew awards to fund their research in neuroscience and cancer. They include a cognitive scientist, Vijay Mohan K Namboodiri, PhD, who is challenging the reigning theory of learning; Justin Eyquem, PhD, a bioengineer who aims to build cancer
Genetic Testing Is the Key to Our Health Secrets
Erin Fusco loves to visit Disneyland. She’s had an annual pass since she was 18 years old and has visited hundreds of times. But there was a stretch when her regular trips to the happiest place on earth were put on hold. When Fusco, now 37, was in her 20s, she was living in the Bay Area with her
UCSF Treats First Patient with Homegrown Chimeric Antigen Receptor (CAR) T-cell Therapy
This month marked an important milestone for UCSF faculty and clinicians working to take on the challenge of glioblastoma multiforme (GBM). They treated their first patient with a promising chimeric antigen receptor (CAR) T-cell therapy that was fully conceived, designed, optimized and manufactured